PURE BIOSCIENCE, INC.

Item 5. Other Information

Chief Executive Officer Transition

On June 15, 2026, PURE Bioscience, Inc. (the “Company”) announced that Robert Bartlett would be retiring from his role as the Company’s Chief Executive Officer, effective August 1, 2026 (the “Transition Date”). Following the Transition Date, Mr. Bartlett will continue in his role as a member of the Company’s Board of Directors (the “Board”) and will act as an advisor to the next Chief Executive Officer. The Company also announced the promotion of Jeffrey Kitchell from his current role as the Company’s President to the Company’s Chief Executive Officer and the appointment of Mr. Kitchell to the Board, in each case, to be effective the Transition Date. The Board approved the Transition and Mr. Kitchell’s promotion and appointment to the Board on June 11, 2026.

Mr. Kitchell, 55, has served as the Company’s President since November 2025. He also serves as the Company’s Corporate Secretary, a role he has had since 2019. Mr. Kitchell oversees day-to-day operations, supports the Company’s functions, and implements new structures and processes. Prior to serving as the Company’s President, Mr. Kitchell served as the Company’s Vice President of Operations from April 2023 to November 2025. In addition, Mr. Kitchell has held various other roles since joining the Company in 2001. In these various roles, he managed the Company’s legal affairs and helped secure its intellectual property. Before joining the Company, Mr. Kitchell held various leadership roles in companies ranging from small to large. Mr. Kitchell earned a Bachelor’s Degree in Business Administration from the University of Phoenix.

The Company expects to enter into an employment agreement with Mr. Kitchell in connection with his promotion to the position of Chief Executive Officer, and once the terms of such agreement are finalized, the Company will file a Current Report on Form 8-K to report the required information within four business days after such information is determined or becomes available.

Except as set forth above, there are no arrangements or understandings between Mr. Kitchell and any other persons pursuant to which he was named to this position with the Company or appointed as a director. There are no family relationships between Mr. Kitchell and any of the Company’s directors or executive officers or any persons nominated or chosen by the Company to be a director or executive officer. Additionally, Mr. Kitchell does not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

Board Member Resignation

On June 15, 2026, the Company also announced that Bernard Blotner resigned as a member of the Board and any committees of the Board, effective June 11, 2026. The resignation was not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

(c) Securities Trading Plans of Directors and Executive Officers

During the quarter ended April 30, 2026, none of our officers or directors, as defined in Rule 16a-1(f), informed us of theadoption ortermination of a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement, each as defined in Regulation S-K Item 408.